- Business Wire•16 hours agoMSD Animal Health Demonstrates Commitment to Eliminate Rabies Worldwide with Donation of More Than Two Million Doses of Vaccine to Date
MSD Animal Health is proud to announce a landmark accomplishment in its fight against rabies with the donation of now more than two million doses of its NOBIVAC® rabies vaccine to organizations working to eliminate this completely preventable disease.
- Business Wire•18 hours agoTwo New Trials of Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy and in Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer to be Presented During Presidential Session at ESMO 2016
Merck , known as MSD outside the United States and Canada, today announced that extensive data on KEYTRUDA® , the company’s anti-PD-1 therapy, have been accepted for presentation at the European Society for Medical Oncology 2016 Congress in Copenhagen, Denmark, Oct.
- Investor's Business Daily•yesterday
Leerink Swann analyst Geoffrey Porges is "tired of waiting" for Gilead Sciences to acknowledge slowing hepatitis C patient volume and competition from rivals AbbVie and Merck.
Merck & Co., Inc. (MRK)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||63.03 x 600|
|Ask||63.30 x 1000|
|Day's Range||62.49 - 63.48|
|52wk Range||47.97 - 64.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.72|
|Avg Vol (3m)||9,616,771|
|Dividend & Yield||1.84 (2.96%)|